{"nct_id":"NCT02290951","title":"Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2015-01-09","start_date_type":"ACTUAL","primary_completion_date":"2025-08-21","primary_completion_date_type":"ACTUAL","completion_date":"2025-08-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["REGN"]}